KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $189.44 $217.57 Friday, 26th Apr 2024 BIIB stock ended at $208.90. This is 3.18% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.89% from a day low at $199.10 to a day high of $210.82.
90 days $189.44 $251.99
52 weeks $189.44 $319.76

Historical Biogen Inc. prices

Date Open High Low Close Volume
Feb 14, 2024 $227.01 $227.99 $220.56 $220.74 2 184 901
Feb 13, 2024 $235.64 $237.00 $225.28 $226.65 3 381 018
Feb 12, 2024 $239.45 $244.94 $239.45 $244.74 947 935
Feb 09, 2024 $239.88 $241.36 $238.90 $240.98 684 165
Feb 08, 2024 $239.89 $240.54 $237.54 $240.30 741 876
Feb 07, 2024 $246.44 $246.44 $240.54 $240.54 755 034
Feb 06, 2024 $241.00 $245.88 $239.96 $245.55 1 275 067
Feb 05, 2024 $242.21 $245.19 $240.50 $241.84 815 861
Feb 02, 2024 $245.93 $246.39 $241.53 $243.72 858 789
Feb 01, 2024 $245.40 $249.33 $240.00 $247.83 896 519
Jan 31, 2024 $247.67 $251.99 $246.28 $246.66 1 064 383
Jan 30, 2024 $245.98 $248.36 $243.58 $247.08 801 400
Jan 29, 2024 $243.41 $248.34 $242.42 $247.52 587 439
Jan 26, 2024 $247.36 $248.07 $244.41 $244.82 532 193
Jan 25, 2024 $247.22 $249.47 $245.25 $246.21 666 802
Jan 24, 2024 $248.34 $250.80 $246.97 $247.16 816 596
Jan 23, 2024 $249.13 $251.86 $248.01 $251.68 707 006
Jan 22, 2024 $250.30 $252.17 $247.07 $248.30 781 041
Jan 19, 2024 $246.96 $251.28 $244.62 $249.96 2 173 640
Jan 18, 2024 $243.89 $247.98 $240.83 $246.97 1 065 567
Jan 17, 2024 $244.71 $246.19 $242.52 $245.27 744 075
Jan 16, 2024 $247.00 $247.56 $244.07 $246.19 946 497
Jan 12, 2024 $248.17 $250.45 $246.73 $248.12 766 342
Jan 11, 2024 $252.29 $252.94 $245.00 $247.21 1 174 466
Jan 10, 2024 $254.36 $255.18 $251.00 $254.23 747 631
Click to get the best stock tips daily for free!

About Biogen Inc.

Biogen. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT